Medikine Inc, based in Menlo Park, CA, is a leading biotechnology company specializing in the development of cytokine mimetics for the treatment of serious diseases. Their innovative approach involves engineering smaller molecules called PEPTIKINES, which offer unique advantages such as enhanced pharmacokinetics and the ability to target specific cells without generating neutralizing antibodies.
With a rich pipeline of therapeutic candidates, Medikine is at the forefront of peptide library screening technology and protein engineering. Led by a team of industry veterans with extensive experience in drug discovery and immuno-oncology therapeutics, the company is dedicated to revolutionizing the field of medicine through their groundbreaking discoveries and optimized therapies based on cytokine mimesis.
Generated from the website